Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema Gulia

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Scientific Reports|August 1, 2025
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancerKripa Bajaj, Sushmita Rath, Deep Vora, et al.
International Journal of Surgical Pathology|July 7, 2025
NKX3.1 Expression in Male Breast Carcinoma: The Phantom MenaceAishwarya Sharma, Aashna Gupta, Gauri Nakra, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Ecancermedicalscience|July 3, 2025
Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in IndiaSushmita Rath, Mehak Trikha, Laboni Sarkar, et al.
Breast (Edinburgh, Scotland)|February 28, 2021
Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, IndiaJyoti Bajpai, Vijay Simha, T S Shylasree, et al.
Scientific Reports|November 4, 2025
Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patientsKhusbhoo A Gandhi, Rohan Chaubal, Elizabeth Talker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled TrialSudeep Gupta, Amita Maheshwari, Pallavi Parab, et al.
Brachytherapy|September 16, 2023
Reirradiation with advanced brachytherapy techniques in recurrent GYN cancersUmesh Mahantshetty, Sheetal R Kashid, Gargee Mulye, et al.
Breast Cancer Research and Treatment|July 12, 2025
Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancerRohan Chaubal, Elizabeth Talker, Jaya Chitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled TrialSudeep Gupta, Nita Nair, Rohini W Hawaldar, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Scientific Reports|August 1, 2025
Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancerKripa Bajaj, Sushmita Rath, Deep Vora, et al.
International Journal of Surgical Pathology|July 7, 2025
NKX3.1 Expression in Male Breast Carcinoma: The Phantom MenaceAishwarya Sharma, Aashna Gupta, Gauri Nakra, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
Ecancermedicalscience|July 3, 2025
Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in IndiaSushmita Rath, Mehak Trikha, Laboni Sarkar, et al.
Breast (Edinburgh, Scotland)|February 28, 2021
Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, IndiaJyoti Bajpai, Vijay Simha, T S Shylasree, et al.
Scientific Reports|November 4, 2025
Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patientsKhusbhoo A Gandhi, Rohan Chaubal, Elizabeth Talker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled TrialSudeep Gupta, Amita Maheshwari, Pallavi Parab, et al.
Brachytherapy|September 16, 2023
Reirradiation with advanced brachytherapy techniques in recurrent GYN cancersUmesh Mahantshetty, Sheetal R Kashid, Gargee Mulye, et al.
Breast Cancer Research and Treatment|July 12, 2025
Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancerRohan Chaubal, Elizabeth Talker, Jaya Chitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled TrialSudeep Gupta, Nita Nair, Rohini W Hawaldar, et al.
Pageof 7